Technology · en
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
Related index pages
Technology · Sky News TechnologyFDA orders blindness risk warning on weight loss drugs
Companies making popular weight loss drugs, including Ozempic and Wegovy, will be required to add a warning label about a rare eye condition that can cause blindness, the US…Read original ↗
Society · Global NewsFDA to require vision loss warning on GLP-1 drug labels
The labelling requirement stems from the findings of a 2024 study and subsequent FDA trials that tested the results of that study.Read original ↗
Technology · Nikkei AsiaSoftBank swings to first-half loss as AI hopes face new setbacks
TOKYO -- SoftBank Group on Tuesday swung to a first-half net loss, as it faces growing uncertainty over its ambitious artificial intelligence strategyRead original ↗
Technology · WIREDScientists May Have Discovered a Massive Starless Galaxy
The promising candidate contains roughly 2 billion times the sun’s mass in hydrogen, yet appears to have no stars.…Read original ↗
World · Nikkei AsiaJapan Tobacco shares tumble on fears of $8bn Russia loss
TOKYO -- Shares in Japan Tobacco have sold off as investors price in a potential loss as big as roughly 1.3 trillion yen ($8.2 billion) on the cigaretRead original ↗
World · GZERO Media